United States · Series A startup

Who invested in SimBioSys

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$15Mraised across 1 round since 2021, from 1 source

Latest round
Series A, $15MOct 2021
Investors
2
See who backed them

The rounds

  1. Oct 2021
    Series A$15M

    Source recorded

Everyone who backed them

Mayo ClinicInvestment firm1round
Northpond VenturesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list SimBioSys as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

AV8VC firmPer its own site
Genoa VenturesVC firmPer its own site

Quick answers about SimBioSys

Who invested in SimBioSys?

SimBioSys's investors include Mayo Clinic and Northpond Ventures.

How much has SimBioSys raised?

SimBioSys has raised $15M across 1 round since 2021.

When did SimBioSys last raise?

SimBioSys's most recent round was a Series A of $15M in Oct 2021.

What was SimBioSys's biggest round?

Its most recent round, $15M in Oct 2021, is also its largest on record.

Who backed SimBioSys first?

SimBioSys's first round on record, in Oct 2021, was backed by Mayo Clinic and Northpond Ventures.

What stage is SimBioSys at?

SimBioSys's latest named round is a Series A, in Oct 2021.

Where is SimBioSys based?

SimBioSys is based in the United States.

Companies like SimBioSys

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.